Scope
Reference
C381280
Description
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux - CM/PHR/22/5732
Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Commercial tool
Establishes a framework
Total value (estimated)
- £176,000,000 excluding VAT
- £211,200,000 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 March 2026 to 29 February 2028
- Possible extension to 28 February 2030
- 4 years
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKC - North East (England)
- UKD - North West (England)
- UKF - East Midlands (England)
- UKG - West Midlands (England)
- UKH - East of England
- UKJ - South East (England)
- UKK - South West (England)
Engagement
Engagement deadline
22 August 2025
Engagement process description
NHS England is advising suppliers of an upcoming tender for the NHS National Framework Agreement for the supply of Low Molecular Weight Heparins and Fondaparinux to commence 1st March 2026 for 24 months with the option to extend for a further 24 months. The purpose of this notice is to inform existing and potential new suppliers that if NHS England believe that it would be beneficial a virtual 1:1 preliminary market meeting can be arranged. Please contact ian.birch1@nhs.net to register your interest. There will also be a 7 day window for queries to be raised via Atamis after all sessions have concluded.
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Publication date of tender notice (estimated)
19 September 2025
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Region: UKI45 - Lambeth
Organisation type: Public authority - central government